UNSPSC 51282601: Cefpirome

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S72Q2F09HY. European Medicines Agency schedules Cefpirome in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07413MIG. Cefpirome generally arises in the molecular formula C22H22N6O5S2.

UNSPSC 51282601 Cefpirome, a Commodity code, appears in state and local procurement records with minimal recent activity directly aligned to its nominal scope. The recent opportunities tagged under this code—naloxone procurement, therapeutic pharmacy initiatives, first aid supplies for fire rescue, and generic multi-source pharmaceuticals—do not substantively address cefpirome, a fourth-generation cephalosporin antibiotic. State and local governments do procure pharmaceuticals and medical supplies through formal bidding and cooperative purchasing, but the cefpirome code shows no concrete solicitation demand in the recent activity block. The mismatch suggests either infrequent direct procurement of this specific antibiotic at the state and local level, misclassification of opportunities in source systems, or reliance on broader pharmaceutical contracts that do not isolate cefpirome as a line item.

The four opportunities cited span Florida (Seminole County naloxone and drug deactivation systems via IFB60459723LAS, due July 26, 2023), Texas (HHS direct-to-manufacturer prescription RFI HHS0017013, due April 3, 2026), Florida (City of Tampa medical and first aid supplies via IFB 26P00145, due March 13, 2026, estimated $700,000.00), and the Minnesota multistate cooperative purchasing vehicle (MMCAP generic pharmaceuticals RFP S1070000015802, due March 26, 2026). These reflect state health departments, counties, cities, and cooperative purchasing alliances as issuing bodies, with geographic spread across Florida, Texas, and Minnesota-led multistate membership. The absence of cefpirome-specific bid opportunities in the recent record signals that pursuit under this code would benefit from direct outreach to health departments, hospital systems, and cooperative purchasing administrators rather than reliance on posted solicitations.